Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intradigm Corp.

Division of Silence Therapeutics PLC
www.intradigm.com

Latest From Intradigm Corp.

Stockwatch: Silence – Nobels and whistles

The 2011 Nobel Prize in Medicine was awarded on 3 October to Bruce Beutler and Jules Hoffmann for discoveries in innate immunity, and to Ralph Steinman for his discovery of the dendritic cell and its role in adaptive immunity. While the headline news is that Steinman's award will proceed even though he died (on 30 September) without knowing of the prize, the timing of the award can serve to remind those in the life sciences that good science – even Nobel-quality science – is not a surrogate for or predictor of subsequent commercial success.

Immune Disorders Israel

Approach for RNAi-focused Silence Therapeutics sees shares rocket

Silence Therapeutics' shares opened at 12.5 pence on 7 September, up 75% on the previous day's opening price, after the company announced that it had been approached by an undisclosed company.

Cardiovascular Deals

AstraZeneca and Silence extend siRNA deal

AstraZeneca and Silence Therapeutics have signed a one-year extension to their R&D collaboration covering siRNA molecules.

Sweden Companies

AstraZeneca and Silence Therapeutics extend siRNA delivery collaboration

AstraZeneca and Silence Therapeutics have agreed a one-year extension to their ongoing small interfering RNA (siRNA) delivery collaboration.

Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Silence Therapeutics PLC
  • Senior Management
  • Xiao-Dong Yang, MD, PhD, VP, Research & Preclin. Dev.
  • Contact Info
  • Intradigm Corp.
    Phone: (650) 855-9696
    3350 W. Bayshore Rd.
    Ste. 100
    Palo Alto, CA 94303
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register